Drugs have the potential to profoundly impact not just the bone marrow, but also the entire spectrum of peripheral blood cells, leading to a wide array of hematologic disorders. These pharmaceutical-induced conditions can affect white blood cells, red blood cells, platelets, and the coagulation system, posing a significant risk in modern pharmacotherapy. Among the drug-induced syndromes, some noteworthy examples include aplastic anemia, agranulocytosis, hemolytic anemia, megaloblastic anemia, thrombocytopenia, methemoglobinemia, sideroblastic anemia, and pure blood cell aplasia. These drug-related hematologic complications underscore the importance of careful monitoring and vigilant management when prescribing and using medications, as they can potentially be life-threatening.
